SEC EDGAR Filing Information

Form SC 13D -- General statement of acquisition of beneficial ownership

Filing Date Changed: 2009-02-20
Documents: 1

SEC Accession No.
0000950162-09-000084
Filing date: 2009-02-20
Accepted: 2009-02-20 14:06:30

Table of submitted documents:

Seq	Type	Document	Size	Description
1	SC 13D	claudio13d_021109.htm	236728	DOR BIOPHARAM/CLAUDIO CAVAZZA SCHEDULE 13D - 02/11/09

		0000950162-09-000084.txt	238557	Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Subject) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-39976 | Film No.: 09624528
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628
609-538-8200

Mailing Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628

CAVAZZA CLAUDIO (Filed by) (0001164803)
Type: SC 13D | Act: | Film No.:

Business Address

Mailing Address
VIA SUDAFRICA 20
ROME ITALY L6 00000